Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2863806 | The American Journal of the Medical Sciences | 2011 | 4 Pages |
Abstract
Octreotide treatment in patients with EVH can result in decreased serum ACE levels, which correlated with the dose of octreotide. The decline in serum ACE levels may be involved in the mechanisms by which octreotide lowers portal vein pressure in EVH treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Qiang MD, Kong-Lin MD, Hui-Jun MD,